allplants, the D2C plant-based food company, has secured a record-breaking GBP38 million Series B funding round led by Draper Esprit, backers of Revolut, Cazoo and Trustpilot.
Investments firm MSD Partners is to make a strategic investment in North American digital consulting firm West Monroe. Chairman & CEO Kevin McCarty and the rest of West Monroe’s senior management team will continue to lead the company following MSD’s investment. West Monroe is a digital consulting firm with eight
PGIM Private Capital provided a USD65.0 million Senior Secured Credit Facility consisting of a USD50.0 million Senior Secured First Lien Term Loan and a USD15.0 million committed Delayed Draw Term Loan to ED&F Man Capital Markets US Holdings, Inc, a global financial brokerage business. “We are pleased to provide funding
Main Capital Partners (Main) has successfully completed the sale of financial software provider b+m Group to German technology investor LEA Partners, representing its first divestment in the DACH region. Main Capital initially acquired b+m from publicly listed Allgeier SE in 2015. During their six year partnership, Main and b+m have
Buyout specialist Kester Capital (Kester), has invested in Rephine, a provider of Good Manufacturing/Clinical Practice (GMP/GCP) audits and regulatory consulting services to the pharmaceutical industry. The investment represents Kester’s fourth investment in the Life Sciences sector, and the fourth investment out of its latest fund, Kester Capital II, which closed
Global Healthcare Exchange (GHX) has acquired Chicago-based Explorer Surgical Corp, operator of a comprehensive digital and remote case support platform that connects suppliers with healthcare provider teams. By combining Explorer Surgical’s digital expertise in creating innovative procedure playbooks, tele-mentoring and performance tracking tools with GHX’s cloud-based supply chain network and
Colorcon, a specialist in pharmaceutical film coatings and specialty excipients, has acquired a majority share in Ideal Cures, a manufacturer of excipients and ready-to-use coating systems for solid oral dosage forms located in India. The acquisition of Ideal Cures underscores the importance of India in the pharmaceutical sector by
Citizens M&A Advisory has served as the exclusive financial advisor to Eclipse Advantage, a provider of outsourced supply chain workforce solutions, on its acquisition by Two Sigma Impact. Eclipse provides a comprehensive suite of labour services for warehouses and distribution centres that increase supply chain productivity and efficiency. Eclipse was
Abalos Therapeutics has completed its Series A funding round bringing the total raised in this round to EUR43 million (USD50 million). The extension was led by Seventure Partners with support from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as contributions from existing investors from the initial Series
Groove, the sales engagement platform for enterprises using Salesforce, has raised a USD45 million Series B round of funding, led by Viking Global Investors. Existing investors Capital One Ventures, Level Equity, Quest Venture Partners, and Uncork Capital also participated in the round. Groove plans to use the funding to expand
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
